American Academy of Pain Medicine (AAPM) 2010 Annual Meeting

San Antonio, TX; February 3-6, 2010

Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Seniors and Younger Patients with Hand Osteoarthritis

Roy D. Altman, MD, University of California-Los Angeles, and colleagues examined the safety and efficacy of diclofenac sodium 1% gel (DSG) in patients age < 65 and ≥ 65 years with hand osteoarthritis (OA). Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age. Read More>>

Assessment for Opioid-Withdrawal Syndrome in Patients with Chronic Moderate-to-Severe Pain Taking ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) ER Capsules

Pellets in ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules (EMBEDA™), which are indicated for treatment of chronic moderate-to-severe pain, contain sequestered naltrexone designed for release to mitigate morphine-induced effects if tampered by crushing. Read More>>

IV Acetaminophen Produces Clinically Meaningful Pain Response and Opioid-Sparing Effect After Major Orthopedic Surgery

San Antonio, TX—After major orthopedic surgery, IV acetaminophen (IV APAP) 1000 mg produced a statistically significant reduction in opioid consumption (33-63% reduction) and significantly reduced the need for opioid rescue, as reported in a study presented at the annual AAPM meeting. Read More>>